246 related articles for article (PubMed ID: 30073853)
1. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles.
Tarantash M; Nosrati H; Kheiri Manjili H; Baradar Khoshfetrat A
Drug Dev Ind Pharm; 2018 Nov; 44(11):1895-1903. PubMed ID: 30073853
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
[TBL] [Abstract][Full Text] [Related]
3. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
4. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
Shen JM; Yin T; Tian XZ; Gao FY; Xu S
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells.
Khodadadi E; Mahjoub S; Arabi MS; Najafzadehvarzi H; Nasirian V
Mol Biol Rep; 2021 Mar; 48(3):2105-2116. PubMed ID: 33635469
[TBL] [Abstract][Full Text] [Related]
6. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
7. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
8. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
[TBL] [Abstract][Full Text] [Related]
9. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of Fe
Atila Dinçer C; Yildiz N; Karakeçili A; Aydoğan N; Çalimli A
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1408-1414. PubMed ID: 27855499
[TBL] [Abstract][Full Text] [Related]
11. Preparation of magnetic albumin nanoparticles via a simple and one-pot desolvation and co-precipitation method for medical and pharmaceutical applications.
Nosrati H; Salehiabar M; Manjili HK; Danafar H; Davaran S
Int J Biol Macromol; 2018 Mar; 108():909-915. PubMed ID: 29101048
[TBL] [Abstract][Full Text] [Related]
12. Phenyl alanine & Tyrosine Amino acids Coated Magnetic Nanoparticles: Preparation and Toxicity study.
Nosrati H; Hamzehei H; Afroogh S; Ashabi SF; Attari E; Manjili HK
Drug Res (Stuttg); 2019 May; 69(5):277-283. PubMed ID: 30189461
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets.
Danafar H; Asadi F; Sharafi A; Manjili HK
Drug Res (Stuttg); 2019 Sep; 69(9):496-504. PubMed ID: 30912092
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells.
Nosrati H; Salehiabar M; Davaran S; Danafar H; Manjili HK
Drug Dev Ind Pharm; 2018 Jun; 44(6):886-894. PubMed ID: 29280388
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
16. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
[TBL] [Abstract][Full Text] [Related]
17. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.
Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME
Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693
[TBL] [Abstract][Full Text] [Related]
18. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.
Rostami S; Tafvizi F; Kheiri Manjili HR
Bioimpacts; 2022; 12(4):301-313. PubMed ID: 35975200
[No Abstract] [Full Text] [Related]
20. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
